Brooklyn Immunotherapeutics Inc (NQ: BTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 14, 2022 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
August 26, 2012
Form S-3
Source: SEC/Edgar
August 26, 2012
Form EFFECT
Source: SEC/Edgar
August 16, 2012
Form 8-K
Source: SEC/Edgar
August 15, 2012
Form S-3/A
Source: SEC/Edgar
August 13, 2012
Form 8-K
Source: SEC/Edgar
August 08, 2012
Form DEL AM
Source: SEC/Edgar
August 05, 2012
Form 8-K
Source: SEC/Edgar
July 31, 2012
Form S-3
Source: SEC/Edgar
July 30, 2012
Form SC 13D/A
Source: SEC/Edgar
July 30, 2012
Form 8-K
Source: SEC/Edgar
July 25, 2012
Form CT ORDER
Source: SEC/Edgar
July 23, 2012
Form 8-K
Source: SEC/Edgar
July 16, 2012
Form 8-K
Source: SEC/Edgar
June 28, 2012
Form DEFA14A
Source: SEC/Edgar
June 04, 2012
Form 8-K
Source: SEC/Edgar
June 03, 2012
Form 8-K
Source: SEC/Edgar
May 22, 2012
Form 8-K
Source: SEC/Edgar
May 21, 2012
Form 8-K
Source: SEC/Edgar
May 20, 2012
Form 8-K
Source: SEC/Edgar
May 13, 2012
Form 8-K
Source: SEC/Edgar
May 09, 2012
Form DEF 14A
Source: SEC/Edgar
April 29, 2012
Form CT ORDER
Source: SEC/Edgar
April 29, 2012
Form 8-K
Source: SEC/Edgar
April 24, 2012
Form 8-K
Source: SEC/Edgar
April 22, 2012
Form 8-K
Source: SEC/Edgar
April 22, 2012
Form 8-K
Source: SEC/Edgar
April 19, 2012
Form 8-K
Source: SEC/Edgar
April 17, 2012
Form 8-K
Source: SEC/Edgar
April 15, 2012
Form 8-K
Source: SEC/Edgar
April 11, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.